top of page

Guggenheim Partners


Generate Biomedicines’ IPO
By Shahmir Ahmed, Alp Ceylan, and Francesco del Sesto (Bocconi University); Diana Usova, Dylan Stiassny, Oli Cedar, Obianuju Okafor (University of Bristol) Photo: Volodymyr Hryshchenko (Unsplash) Summary of IPO As the pharmaceutical industry looks to artificial intelligence to accelerate drug discovery, Generate Biomedicines are positioning themselves as a force to be reckoned with in this growing market. Through what the company has dubbed “Generative Biology”, millions of p
Mar 23


Bain Capital’s $5.3bn Acquisition of Guidehouse
By Jian Wee Soh, Kai Ye, Bharath Sivakumar, Aaren Tan, Arfred Garcia (Imperial College London), Devina Aggarwal, Atin Narain, Omar Ali,...
Jan 11, 2024


Xylem’s $7.5bn Acquisition of Evoqua
By Jack Lee, Heather Leung and Sissi Zeng (HKUST), Rhys Meredith, Kian Patel, Oliver Platts, Samuel McCrea, Velizar Zlatev and Salah...
Mar 15, 2023


X-energy’s $2.3bn SPAC Merger with Ares Acquisition Corp.
By Sean Millar, Matthew Moran and Pramoth Ragavan (University of St Andrews), and Adil Amlaiky (McGill University) Photo: Hal Gatewood...
Mar 3, 2023
bottom of page
